
What Are The Causes And Risk Factors Of Skin Cancer?
Race
Ultraviolet Radiation



Gender

Previous Radiotherapy Treatment


Biological Agents



Viral Infections



Organ Transplantation


Chemical Exposure

Pre-existed Lesions


Genetics




Skin Conditions
Albinism




Benign pigmental naevi


Recessive Dystrophic Epidermolysis Bullosa



Xeroderma Pigmentosum


Psoriasis


Chronic Wounds

Cancers



Psoralen–UVA therapy

Obesity
What Is Obesity?



Are You Unsure Of How To Calculate BMI?
The National Health Service (NHS) has provided a guide on how to calculate one’s BMI. Please click the link below
https://www.nhs.uk/health-assessment-tools/calculate-your-body-mass-index/
The Role Of Leptin





The Function Of The Leptin Hormone

What happens when there is dysfunction of the leptin?

What Conditions Is Leptin Associated With?

What Is Inflammation?


Theories On The Role Of Obesity And Leptin In Skin Cancer
Theory One: Leptin Resistance




Theory Two: Increase in proliferation connects leptin with obesity and enhances the risk of migration and angiogenesis.


Theory three: Leptin can induce mitosis


Theory four: Cav-1 and FASN expression





Theory five: Obesity forms a pro-cancerous microenvironment
Theory six: Obesity promotes mesenchymal cell phenotype to induce metastasis



Recommended Sources
Spotting Cancer: Skin Cancer Guide
References
Arbel, Y., Arbel, Y., Kerner, A. and Kerner, M. (2023). Is obesity a risk factor for melanoma? BMC Cancer, 23(1). doi: https://doi.org/10.1186/s12885-023-10560-8.
Bernstein, S. (2024). What Are Psoralens? Available at: https://www.webmd.com/skin-problems-and-treatments/psoriasis/what-are-psoralens (Accessed: 8th February 2026)
Bhowmick, S., Biswas, T., Ahmed, M., Roy, D., and Mondal, S. (2023). Caveolin-1 and lipids: Association and their dualism in oncogenic regulation. Biochimica et Biophysica Acta (BBA) – Reviews on Cancer, 1878(6), p.189002. doi: https://doi.org/10.1016/j.bbcan.2023.189002.
Biology Insights (2025) What Causes Leptin Resistance & How to Reverse It? Available at: https://biologyinsights.com/what-causes-leptin-resistance-how-to-reverse-it/ (Accessed: 9th February 2026)
Cassidy, J., Bissett, D., Spene, R., and Payne, M. (2010). Oxford Handbook of Oncology. Oxford: Oxford University Press
Dopytalska, K., Baranowska-Bik, A., Roszkiewicz, M., Bik, W. and Walecka, I. (2020). The role of leptin in selected skin diseases. Lipids in Health and Disease, 19(1). doi: https://doi.org/10.1186/s12944-020-01391-8.
Jiménez-Cortegana, C., López-Saavedra, A., Sánchez-Jiménez, F., Pérez-Pérez, A., Castiñeiras, J., Virizuela-Echaburu, J.A., de la Cruz-Merino, L. de la and Sánchez-Margalet, V. (2021). Leptin, Both Bad and Good Actor in Cancer. Biomolecules, 11(6), p.913. doi: https://doi.org/10.3390/biom11060913.
Karantanos, T., Karanika, S., Wang, J., Yang, G., Dobashi, M., Park, S., Ren, C., Li, L., Basourakos, S.P., Hoang, A., Efstathiou, E., Wang, X., Troncoso, P., Titus, M., Broom, B., Kim, J., Corn, P.G., Logothetis, C.J,. and Thompson, T.C. (2016). Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer. Oncotarget, 7(29), pp.46321–46334. doi: https://doi.org/10.18632/oncotarget.10113.
Modak, S., Aktar, T., Majumder, D., Singha, A.Kr. and Maiti, D. (2025). A systematic review on leptin’s role in defining cancer: special emphasis on immunomodulation, inflammation, and therapeutic interventions. Genes & Immunity, 26(3), pp.266–286. doi: https://doi.org/10.1038/s41435-025-00333-7.
Neagu, M. and Dobre, E.-G. (2024). New Insights into the Link Between Melanoma and Obesity. Advances in Experimental Medicine and Biology, pp.851–867. doi: https://doi.org/10.1007/978-3-031-63657-8_28.
Roky, A.H., Islam, M.M., Fuad, M., Mostaq, M.S., Mahmud, M.Z. Amin, M.N., and Mahmud, M.A. (202.4). Overview of skin cancer types and prevalence rates across continents. Cancer Pathogenesis and Therapy, 3(2). doi: https://doi.org/10.1016/j.cpt.2024.08.002.
Scott, F.I., Mamtani, R., Brensinger, C.M., Haynes, K., Chiesa-Fuxench, Z.C., Zhang, J., Chen, L., Xie, F., Yun, H., Osterman, M.T., Beukelman, T., Margolis, D.J., Curtis, J.R., and Lewis, J.D. (2016). Risk of Nonmelanoma Skin Cancer Associated with the Use of Immunosuppressant and Biologic Agents in Patients with a History of Autoimmune Disease and Nonmelanoma Skin Cancer. JAMA Dermatology, 152(2), p.164. doi: https://doi.org/10.1001/jamadermatol.2015.3029.
Su, X., Cheng, Y. and Chang, D. (2021). The Important Role of Leptin in Modulating the Risk of Dermatological Diseases. Frontiers in Immunology, [online] 11. doi: https://doi.org/10.3389/fimmu.2020.593564.
Updated: February 2026 Next Review: May 2028




























































